Selegiline Transdermal System for the Treatment of Cocaine Dependence - 1

Completed · Phase 3

Conditions studied: Cocaine-Related Disorders

In brief

The purpose of this study is to evaluate the Selegiline Transdermal System for the treatment of cocaine dependence.

Key facts

Study ID
NCT00032929
Run by
National Institute on Drug Abuse (NIDA)
People needed
269
Starts
2001-03-01
Last updated by the study team
2017-01-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.